HeartStart HS1 Defibrillator* Event Registry

Launched by PHILIPS CLINICAL & MEDICAL AFFAIRS GLOBAL · Apr 7, 2021

Keywords

ClinConnect Summary

The HeartStart HS1 Defibrillator Event Registry is a clinical trial that is looking at how well and safely the HeartStart HS1 defibrillator works in people who have experienced sudden cardiac arrest. This study is currently recruiting participants of all ages and genders who have been suspected of having a heart-related emergency and have had the HeartStart HS1 defibrillator used with specific pads applied to them, even if they did not receive a shock.

To be eligible for this trial, participants must have had the HeartStart HS1 device used on them during an emergency situation. However, if they used a different type of defibrillator or the HeartStart device was only used for training, they won't be able to participate. Those who join the study can expect their experience with the HeartStart device to be recorded and analyzed, which will help researchers understand its effectiveness in real-life situations. This information could improve how we respond to cardiac emergencies in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have been suspected of a circulatory arrest for any cause.
• * Have had HeartStart HS1 Defibrillator with electrodes:
• • Adult SMART Pads Cartridge \[REF: M5071A\], Infant/Child SMART Pads Cartridge (REF:M5072A) applied to their body and powered up with HS1 battery (Model M5070A), regardless of whether a defibrillation shock was delivered
• Exclusion Criteria:
• * Subjects will be excluded if any of the following are present:
• • AED or pad use other than the HeartStart HS1 Defibrillator with above referenced Philips electrode pads. Note: Use of a device other than the Philips HeartStart HS1 AED does not preclude enrollment if the AED or an Advanced Life Support defibrillator was used after the HeartStart HS1 AED.
• • AED used for training purposes.